Overview

Efficacy and Safety of Etoricoxib/Tizanidine Versus Etoricoxib for Acute Low Back Pain Associated to Muscle Spasm

Status:
RECRUITING
Trial end date:
2025-07-30
Target enrollment:
Participant gender:
Summary
This is a Phase III, longitudinal, multicenter, randomized, double-blind clinical trial. The aim of the study is to evaluate the efficacy and safety of a fixed-dose combination of etoricoxib and tizanidine compared to etoricoxib alone in patients with acute low back pain associated with muscle spasms.
Phase:
PHASE3
Details
Lead Sponsor:
Laboratorios Silanes S.A. de C.V.
Treatments:
Etoricoxib
tizanidine